TwinBeech Capital’s Gossamer Bio GOSS Stock Holding History

TwinBeech Capital’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-42,536	Closed	-$50.2K	–	641
2024 Q1	$50.2K	Buy	+42,536	New	+$46.8K	﹤0.01%	514

Other funds holding GOSS

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TwinBeech Capital's GOSS Position: Q2 2024 in Review

TwinBeech Capital sold out of Gossamer Bio (GOSS) in Q2 2024, closing a stake of 42,536 shares — an estimated $50.2K sold.

TwinBeech Capital first reported a position in GOSS in Q1 2024 and held it in 1 quarter. The position peaked at $50.2K in Q1 2024. 94 funds tracked by Wall St. Rank hold GOSS as of Q2 2024.

TwinBeech Capital reported no remaining Gossamer Bio position as of Q2 2024 after selling out during the quarter.
TwinBeech Capital sold 42,536 Gossamer Bio shares in Q2 2024, an estimated $50.2K.
TwinBeech Capital first reported a position in Gossamer Bio in Q1 2024 and held it in 1 quarter.
TwinBeech Capital's Gossamer Bio position peaked at $50.2K in Q1 2024.
94 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2024.

Based on TwinBeech Capital's 13F filing for Q2 2024, filed 14 Aug 2024.